NOV: 1 More Deal to Cement Its Dominance

Before you go, we thought you'd like these...
Before you go close icon

In today's video, energy editor Joel South discusses National Oilwell Varco's $2.5 billion acquisition bid for oil and gas machinery manufacturer Robbins & Myers. Unlike past acquisitions, National Oilwell would be taking on a proven manufacturer with strong cash-generating abilities as well as industry-leading blowout preventers and artificial lift pumps. Check out the video below to hear how Robins & Myers fits into NOV's plans to maintain its global oil and gas equipment dominance.

Some say NOV stands for "no other vender," giving us an insight into the absolute supremacy the company has over its competitors. More than 90% of rigs globally have equipment from National Oilwell, clearly making it a United States company exercising its prowess all over the world. However, there are other companies with this omnipotence in their respective sectors. Interested in finding out who these companies are? Check out our free report "3 American Companies Set to Dominate the World." Click here to get your free copy before it's gone.

The article NOV: 1 More Deal to Cement Its Dominance originally appeared on Fool.com.

Joel South owns shares of Halliburton. The Motley Fool owns shares of Halliburton and National Oilwell Varco. Motley Fool newsletter services recommend Halliburton and National Oilwell Varco. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners